157 related articles for article (PubMed ID: 26473674)
1. Efficacy Evaluation of an Inactivated Duck Tembusu Virus Vaccine.
Lin J; Liu Y; Wang X; Yang B; He P; Yang Z; Duan H; Xie J; Zou L; Zhao J; Pan J
Avian Dis; 2015 Jun; 59(2):244-8. PubMed ID: 26473674
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and protective efficacy of an EB66
Yang Z; Wang J; Wang X; Duan H; He P; Yang G; Liu L; Cheng H; Wang X; Pan J; Zhao J; Yu H; Yang B; Liu Y; Lin J
Avian Pathol; 2020 Oct; 49(5):448-456. PubMed ID: 32374185
[TBL] [Abstract][Full Text] [Related]
3. Efficacy assessment of an inactivated Tembusu virus vaccine candidate in ducks.
Zhang L; Li Z; Zhang Q; Sun M; Li S; Su W; Hu X; He W; Su J
Res Vet Sci; 2017 Feb; 110():72-78. PubMed ID: 28159240
[TBL] [Abstract][Full Text] [Related]
4. The vaccine efficacy of recombinant duck enteritis virus expressing secreted E with or without PrM proteins of duck tembusu virus.
Chen P; Liu J; Jiang Y; Zhao Y; Li Q; Wu L; He X; Chen H
Vaccine; 2014 Sep; 32(41):5271-7. PubMed ID: 25087676
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 shows high adjuvanticity for an inactivated vaccine against duck Tembusu virus disease.
Gao X; Ren X; Zhang S; Song H; Guo X; Jia H; Xin T; Jiang Y; Zhang Z; Hou S
Poult Sci; 2020 Dec; 99(12):6454-6461. PubMed ID: 33248560
[TBL] [Abstract][Full Text] [Related]
6. pUC18-CpG Is an Effective Adjuvant for a Duck Tembusu Virus Inactivated Vaccine.
Ren X; Wang X; Zhang S; Gao X; Fang L; Wang X; Lin W; Jia H; Guo X; Xin T; Zhu H; Lin J; Hou S
Viruses; 2020 Feb; 12(2):. PubMed ID: 32093377
[TBL] [Abstract][Full Text] [Related]
7. Development of an attenuated live vaccine candidate of duck Tembusu virus strain.
He D; Zhang X; Chen L; Tang Y; Diao Y
Vet Microbiol; 2019 Apr; 231():218-225. PubMed ID: 30955813
[TBL] [Abstract][Full Text] [Related]
8. Development of a live attenuated vaccine candidate against duck Tembusu viral disease.
Li G; Gao X; Xiao Y; Liu S; Peng S; Li X; Shi Y; Zhang Y; Yu L; Wu X; Yan P; Yan L; Teng Q; Tong G; Li Z
Virology; 2014 Feb; 450-451():233-42. PubMed ID: 24503086
[TBL] [Abstract][Full Text] [Related]
9. Immunization with a suicidal DNA vaccine expressing the E glycoprotein protects ducklings against duck Tembusu virus.
Tang J; Bi Z; Ding M; Yin D; Zhu J; Zhang L; Miao Q; Zhu Y; Wang G; Liu G
Virol J; 2018 Sep; 15(1):140. PubMed ID: 30217161
[TBL] [Abstract][Full Text] [Related]
10. Inactivated vaccine for protection against duck virus enteritis.
Shawky SA; Sandhu TS
Avian Dis; 1997; 41(2):461-8. PubMed ID: 9201416
[TBL] [Abstract][Full Text] [Related]
11. Liposomes containing recombinant E protein vaccine against duck Tembusu virus in ducks.
Ma T; Liu Y; Cheng J; Liu Y; Fan W; Cheng Z; Niu X; Liu J
Vaccine; 2016 Apr; 34(19):2157-63. PubMed ID: 27016654
[TBL] [Abstract][Full Text] [Related]
12. Duck IL-7 as a novel adjuvant improves the humoral immune response to an inactivated duck tembusu virus vaccine.
Huang J; Yu T; Long Z; Wang M; Liu M; Zhu D; Chen S; Zhao X; Yang Q; Wu Y; Zhang S; Ou X; Mao S; Tian B; Gao Q; Sun D; Jia R; Cheng A
Vet Microbiol; 2023 Apr; 279():109665. PubMed ID: 36716633
[TBL] [Abstract][Full Text] [Related]
13. Long-term passage of duck Tembusu virus in BHK-21 cells generates a completely attenuated and immunogenic population with increased genetic diversity.
Zhang L; Sun M; Zhang Q; Wang J; Cao Y; Cui S; Su J
Vaccine; 2020 Jan; 38(4):933-941. PubMed ID: 31708180
[TBL] [Abstract][Full Text] [Related]
14. Oral Vaccination with a DNA Vaccine Encoding Capsid Protein of Duck Tembusu Virus Induces Protection Immunity.
Huang J; Shen H; Jia R; Wang M; Chen S; Zhu D; Liu M; Zhao X; Yang Q; Wu Y; Liu Y; Zhang L; Yin Z; Jing B; Cheng A
Viruses; 2018 Apr; 10(4):. PubMed ID: 29642401
[TBL] [Abstract][Full Text] [Related]
15. A recombinant adenovirus expressing the E protein of duck Tembusu virus induces protective immunity in duck.
Tang J; Yin D; Wang R; Zhou Q; Zhou X; Xing X; Liu HM; Liu G; Wang G
J Vet Med Sci; 2019 Feb; 81(2):314-320. PubMed ID: 30584200
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of immunogenicity and protective efficacy of a CpG-adjuvanted DNA vaccine against Tembusu virus.
Chen H; Yan M; Tang Y; Diao Y
Vet Immunol Immunopathol; 2019 Dec; 218():109953. PubMed ID: 31590073
[TBL] [Abstract][Full Text] [Related]
17. [Development and evaluation of an inactivated bivalent vaccine against duck viral hepatitis].
Yin F; Jing L; Zhang S; Yu M; Zhang W; Fan G; Dong X; Liu W
Sheng Wu Gong Cheng Xue Bao; 2015 Nov; 31(11):1579-88. PubMed ID: 26939441
[TBL] [Abstract][Full Text] [Related]
18. Efficacy study and field application of an inactivated new type gosling viral enteritis virus vaccine for domestic geese.
Chen S; Ma GP; Wang MS; Cheng AC; Zhu DK; Luo QH; Jia RY; Liu F; Chen XY; Han XF; Bo Y; Zhou DC
Poult Sci; 2011 Apr; 90(4):766-74. PubMed ID: 21406361
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
[TBL] [Abstract][Full Text] [Related]
20. Development of a solid-phase competition ELISA to detect antibodies against newly emerged Duck Tembusu virus.
Fu Y; Ji Y; Liu B; Dafallah RM; Zhu Q
J Virol Methods; 2015 Nov; 224():73-6. PubMed ID: 26320577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
